The Court of Justice of the European Union has today, December 19, outlined the scope of protection held by owners of plant variety rights in a decision involving a variety of mandarin.
US-based Eagle Pharmaceuticals has dropped its patent infringement and antitrust claims against Eli Lilly.
Nestlé Skin Health will not face claims that it misappropriated trade secrets related to a training platform for teaching medical professionals how to perform facial injections, a US court has ruled.
Squire Patton Boggs has appointed Janice Rice to deputy practice group leader of its IP and technology practice, where she will lead the life and health sciences team.
A subsidiary of Pfizer, Hospira, infringed one of Amgen’s patents and must pay damages of $70 million, the US Court of Appeal for the Federal Circuit has affirmed.
The US Patent and Trademark Office is coming under increasing pressure to review allegations that Gilead delayed development of its latest HIV drug in order to maximise profits.
In a 72-18 vote, the US Senate has confirmed Stephen Hahn as the new commissioner of the Food and Drug Administration.
Merck & Co has announced its acquisition of cancer research biotech ArQule in a $2.7 billion deal.
Momenta Pharmaceuticals has agreed to pay $35 million to settle a 2015 class-action suit that claimed that it blocked generics of the blockbuster blood clot drug enoxaparin from coming to market.
The US, Canada and Mexico have signed a new, finalised trade agreement to replace the old North American Free Trade Agreement.